Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
With advances in molecular biologic and genomic technology, detailed molecular mechanisms for development of castration-resistant prostate cancer (CRPC) have surfaced. Metastatic prostate cancer (PCa) no longer represents an end stage, with many emerging therapeutic agents approved as effective in p...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
China Medical University
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264971/ |